Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.
Launched by WOMAN'S HEALTH UNIVERSITY HOSPITAL, EGYPT · Jul 5, 2013
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
NAC has been used effectively as an adjuvant to clomiphene citrate (CC) for ovulation induction in CC-resistant women with PCOS .
Because it is an insulin sensitizer, NAC was proposed as an adjuvant to clomiphene citrate for ovulation induction in patients with polycystic ovary syndrome who are resistant to clomiphene citrate. Encouraging results in those patients stimulated us to investigate whether adding NAC to the standard treatment with CC results in a higher ovulation rate, higher pregnancy rate, and less CC resistance in women with newly diagnosed polycystic ovary syndrome using a r...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • PCOS diagnosed by Rotterdam's criteria
- Exclusion Criteria:
- • previous induction of ovulation male factoe infertility tubal factor infertility uterine factor infertility
About Woman's Health University Hospital, Egypt
Women's Health University Hospital in Egypt is a leading institution dedicated to advancing women's health through innovative clinical research and comprehensive patient care. As a prominent clinical trial sponsor, the hospital focuses on a wide range of health issues affecting women, including reproductive health, maternal care, and gynecological conditions. With a commitment to scientific excellence and ethical standards, the hospital collaborates with renowned researchers and healthcare professionals to deliver impactful studies that enhance treatment options and improve health outcomes for women. Through its robust infrastructure and multidisciplinary approach, Women's Health University Hospital aims to contribute significantly to the global body of knowledge in women's health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alaa M Ismail, M D
Principal Investigator
Woman's Health University Hospital, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials